Domov › Nemalicelični pljučni rak › Minnesota › Saint Paul
Klinične študije za Nemalicelični pljučni rak v Saint Paul, MN
19 študij za Nemalicelični pljučni rak išče udeležence na lokacijah v Saint Paul in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Vključevanje udeležencevFaza 3
- United Hospital, Saint Paul
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Vključevanje udeležencevFaza 3
- Regions Hospital, Saint Paul
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Vključevanje udeležencevFaza 3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Vključevanje udeležencevFaza 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi stran
- Minnesota Oncology Hematology, PA, Woodbury · 7 mi stran
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Minnesota Oncology Hematology, P.A., Maplewood · 5 mi stran
- Minnesota Oncology Hematology, P.A., Woodbury · 7 mi stran
- in še 1
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Vključevanje udeležencevFaza 3
- Regions Hospital, Saint Paul
- M Health Fairview St. John's Hospital, Maplewood · 5 mi stran
- Minnesota Oncology Hematology PA, Maplewood · 5 mi stran
- in še 1
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
Vključevanje udeležencevFaza 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi stran
- in še 3
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Vključevanje udeležencevFaza 3
- Clinical Study Site, Saint Paul
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- HealthPartners Cancer Research Center, Saint Paul
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Vključevanje udeležencevFaza 3
- Research Site, Saint Paul
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Vključevanje udeležencevFaza 1/2
- USOR Minnesota Oncology Hematology, Maplewood · 5 mi stran
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
Vključevanje udeležencevFaza 1/2
- Health Partners Cancer Center at Regions Hospital, Saint Paul
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
Vključevanje udeležencevFaza 1/2
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Allina Health Cancer Institute - United Hospital, Saint Paul
- Allina Health Cancer Institute, Saint Paul
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Vključevanje udeležencevFaza 2/3
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Woodbury, Woodbury · 7 mi stran
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Regions Hospital, Saint Paul
- United Hospital, Saint Paul
- Minnesota Oncology Hematology PA-Maplewood, Maplewood · 5 mi stran
- in še 3
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- Research Site 121, Saint Paul
Študije za Nemalicelični pljučni rak v drugih mestih
- Houston, TX145 študij
- New York City, NY121 študij
- Arlington, VA104 študij
- Nashville, TN97 študij
- Boston, MA90 študij
- Los Angeles, CA87 študij
- St. Louis, MO73 študij
- Chicago, IL61 študij
- Baltimore, MD60 študij
- San Antonio, TX59 študij
- Columbus, OH57 študij
- Washington, DC55 študij
Druge študije v Saint Paul
- Rak prostate13 študij
- Rak pljuč13 študij
- Rak dojke12 študij
- Kolorektalni rak9 študij
- Rak jajčnikov8 študij
- Metastatski rak7 študij
- Rak ledvic (renocelularni karcinom)7 študij
- Rak endometrija6 študij
- Rak mehurja6 študij
- Melanom6 študij
- Ploščatocelični karcinom glave in vratu6 študij
- Akutna mieločna levkemija6 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.